DE69229948T2 - hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN - Google Patents

hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN

Info

Publication number
DE69229948T2
DE69229948T2 DE69229948T DE69229948T DE69229948T2 DE 69229948 T2 DE69229948 T2 DE 69229948T2 DE 69229948 T DE69229948 T DE 69229948T DE 69229948 T DE69229948 T DE 69229948T DE 69229948 T2 DE69229948 T2 DE 69229948T2
Authority
DE
Germany
Prior art keywords
hgpiib
fragments
vivo
vitro methods
thrombotic events
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69229948T
Other languages
English (en)
Other versions
DE69229948D1 (de
Inventor
Mark Ginsberg
Andrew Frelinger
Edward Plow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of DE69229948D1 publication Critical patent/DE69229948D1/de
Application granted granted Critical
Publication of DE69229948T2 publication Critical patent/DE69229948T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DE69229948T 1991-04-30 1992-04-27 hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN Expired - Fee Related DE69229948T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69338891A 1991-04-30 1991-04-30
PCT/US1992/003419 WO1992019760A1 (en) 1991-04-30 1992-04-27 In vitro methods for determining in vivo thrombotic events

Publications (2)

Publication Number Publication Date
DE69229948D1 DE69229948D1 (de) 1999-10-14
DE69229948T2 true DE69229948T2 (de) 2000-03-16

Family

ID=24784451

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229948T Expired - Fee Related DE69229948T2 (de) 1991-04-30 1992-04-27 hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN

Country Status (10)

Country Link
US (5) US5763580A (de)
EP (1) EP0583352B1 (de)
AT (1) ATE184286T1 (de)
AU (1) AU7407096A (de)
CA (1) CA2102115C (de)
DE (1) DE69229948T2 (de)
DK (1) DK0583352T3 (de)
ES (1) ES2136085T3 (de)
GR (1) GR3031803T3 (de)
WO (1) WO1992019760A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0583352B1 (de) * 1991-04-30 1999-09-08 The Scripps Research Institute hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN
US6046316A (en) * 1997-12-09 2000-04-04 Wayne State University Nucleic acid encoding truncated integrins
US6623981B2 (en) 1998-01-27 2003-09-23 Bristol-Myers Squibb Company Detection of patients at risk for developing integrin antagonist/agonist mediated disease states
CA2331244C (en) * 2000-01-21 2009-06-30 Anchor Coin, Inc. Method and apparatus for awarding and redeeming promotional points at an electronic game
US20050233390A1 (en) * 2003-04-09 2005-10-20 Allen John W Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion
US5196511A (en) * 1989-12-01 1993-03-23 The Scripps Research Institute Peptides and antibodies that inhibit integrin-ligand binding
US5436163A (en) * 1989-12-01 1995-07-25 The Blood Center Of Southeastern Wisconsin Polymorphism of human platelet membrane glycoprotein IIb and diagnostic applications thereof
EP0583352B1 (de) * 1991-04-30 1999-09-08 The Scripps Research Institute hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN

Also Published As

Publication number Publication date
EP0583352B1 (de) 1999-09-08
GR3031803T3 (en) 2000-02-29
DE69229948D1 (de) 1999-10-14
WO1992019760A1 (en) 1992-11-12
AU1782892A (en) 1992-12-21
US20020177173A1 (en) 2002-11-28
AU671419B2 (en) 1996-08-29
US6787320B2 (en) 2004-09-07
US7122324B2 (en) 2006-10-17
US6063907A (en) 2000-05-16
EP0583352A1 (de) 1994-02-23
US20050136482A1 (en) 2005-06-23
US5763580A (en) 1998-06-09
CA2102115C (en) 2009-04-07
ES2136085T3 (es) 1999-11-16
AU7407096A (en) 1997-01-30
EP0583352A4 (de) 1995-06-14
CA2102115A1 (en) 1992-10-31
US6323324B1 (en) 2001-11-27
ATE184286T1 (de) 1999-09-15
DK0583352T3 (da) 1999-12-20

Similar Documents

Publication Publication Date Title
GR3029740T3 (en) Fragments of prion proteins.
ATE128183T1 (de) Peptide und antikörper, die die bindung von blutplättchen verhindern.
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
WO2000045176A3 (de) VERFAHREN ZUM NACHWEIS VON N-TERMINALEM proBNP
DE69504959T2 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
HK1021229A1 (en) A in vitro method of determining the presence of aprotein in an isolated biological sample.
DE68917273T2 (de) Testmethode und Gerät zur Bestimmung des gesamten Proteins.
DE69229948T2 (de) hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN
DE69312185D1 (de) Chromatographischer Sandwichtest zur Bestimmung von spezifischen Antikörpern und Vorrichtung hierfür
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
ATE153770T1 (de) Künstliche standard- und kontrollseren zur verwendung in verfahren zur bestimmung von antikörpern
ATE154395T1 (de) Monoklonale antikörper
SE9601231D0 (sv) Monoclonal antibody
DE69333683D1 (de) Antikörper-testbesteck zur bestimmung von amylin
DE29508576U1 (de) Antikörper gegen das 42kDa-Protein aus Säugerzellen und Testsysteme zur Tumordiagnostik
NO952506L (no) Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee